Showing results (1-10 of 313) with videos related to
Sort By:
Pageof 32
Eclinicalmedicine|November 26, 2024
Real-world data: bridging the gap between clinical trials and practiceBrooke E Wilson, Christopher M BoothCancer|November 2, 2023
Efficacy-effectiveness gaps in oncology: Looking beyond survivalBrooke E Wilson, Timothy P Hanna, Christopher M BoothJournal of the National Cancer Institute|September 26, 2025
"While you are on chemotherapy…": common recommendations that lack evidence and may cause harmBrooke E Wilson, Christopher Jackson, Michelle Tregear, et al.Cancer|June 21, 2023
Differential treatment effect between younger and older adults for new cancer therapies in solid tumors supporting US Food and Drug Administration approval between 2010 and 2021Brooke E Wilson, Alexandra Desnoyers, Michelle B Nadler, et al.Cancer|September 26, 2023
Meta-analysis of sex and racial subgroup participation rates and differential treatment effects for trials in solid tumor malignancies leading to US Food and Drug Administration registration between 2010 and 2021Brooke E Wilson, Michelle B Nadler, Alexandra Desnoyers, et al.JAMA Network Open|April 15, 2025
Health Care Contact Days and Outcomes in Clinical Trials vs Routine Care Among Patients With Non-Small Cell Lung CancerArjun Gupta, Paul Nguyen, Brooke E Wilson, et al.Journal of the National Cancer Institute|May 23, 2025
Analysis of 2023 World Health Organization cancer Essential Medicines List and concordance with resource stratified guidelinesBrooke E Wilson, Kristin Wright, Manju Sengar, et al.The Lancet. Oncology|March 28, 2024
Cost and value of cancer medicines in a single-payer public health system in Ontario, Canada: a cross-sectional studyJoseph C Del Paggio, Rohini Naipaul, Scott Gavura, et al.The Lancet. Oncology|June 3, 2023
Global application of National Comprehensive Cancer Network resource-stratified guidelines for systemic treatment of colon cancer: a population-based, customisable model for cost, demand, and procurementBrooke E Wilson, Christopher M Booth, Richard Sullivan, et al.Cancer|October 6, 2021
Trends in drug revenue among major pharmaceutical companies: A 2010-2019 cohort studyDaniel E Meyers, Benjamin S Meyers, Timothy M Chisamore, et al.Pageof 32